About Genelux Corporation Common Stock
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Market Cap
$0.11B
Employees
25
Listed Since
January 26, 2023
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.genelux.comPhone
805-267-9889
Headquarters
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
CIK
0001231457